With the lack of products in the pharma research pipelines and the high cost of development, we at CYGNOS Biotech believe our business model is an alternative solution to the current pharma paradigm. We are decentralizing the process by developing partnerships and collaborations that fulfill the continuum of services necessary for new product development. In an effort to be cost effective, promote quality, and enhance creativity and innovation, CYGNOS Biotech is creating a strong network foundation of partners and collaborators. We have extended participation by product to both private and academic researchers, clinical practitioners, para-professionals, contract manufacturers, market and distribution experts and other industry stakeholders.
If you have an interest in seeking further information or in participating in these clinical studies or trials, please contact us.